SAT-087 MALIGNANT HYPERTENSION IN IGA NEPHROPATHY WITH THROMBOTIC MICROANGIOPATHY

Malignant hypertension (MHT) concerns 7 to 15% of IgA nephropathy (IgAN) patients. In some studies, a significant association of MHT with microangiopathy in IgAN has been reported. Herein, we describe the prevalence and characteristics of MHT in primitive IgAN patients with thrombotic microangiopathy (TMA).